DHP Healthcare – Financing expansion plans
DHP Healthcare was looking to expand its portfolio of medications to include a new migraine relief product. Because of the nature of the industry, DHP Healthcare is restricted to using one distributor, a subsidary of a large listed company. The company is currently working on 45 day terms and has not required extra finance until it recently formulated new growth plans. In order to raise the required capital, the company looked at a number of options including invoice finance and a bank loan.
The Marketinvoice Solution
DHP Healthcare had never heard of a finance model like MarketInvoice. However, director Anthony Hodges quickly understood how well suited it was for the business and its needs when compared with traditional factoring.
The first auction on the MarketInvoice platform attracted significant investor interest, given the profile of the debtor’s parent organisation. It was successfully bought out at DHP Healthcare’s ideal parameters: an advance rate of 85% and 1.25% discount fee.
DHP Healthcare is very happy with the solution provided by MarketInvoice and has since referred MarketInvoice to other companies operating in the pharmaceutical sector.